Results 151 to 160 of about 219,075 (257)
ABSTRACT Background/Purpose Although type 1 autoimmune pancreatitis (AIP) responds well to corticosteroids, spontaneous remission can also occur. This study evaluated long‐term outcomes and predictors of delayed steroid initiation in AIP patients initially managed conservatively.
Yasuhiro Kuraishi +9 more
wiley +1 more source
Editorial: Metabolic and biomechanical factors in bone fragility: new frontiers in understanding and managing osteoporosis. [PDF]
Asadipooya K.
europepmc +1 more source
Abstract Background Identifying individuals at high risk for developing peri‐implantitis (PI) and then determining the prognosis for implants with PI is crucial for treatment planning. Methods This study longitudinally followed implants from implant placement retrospectively.
Muhammad H. A. Saleh +9 more
wiley +1 more source
Association Between the Use of Proton Pump Inhibitors and Osteoporosis/Fracture: Nested Case-Control Studies Using a National Health Screening Cohort. [PDF]
Youk H +5 more
europepmc +1 more source
Abstract Background Fibroblast growth factor‐2 (FGF‐2) is a novel agent utilized in periodontal regeneration therapy. However, its clinical efficacy compared with autologous bone graft (ABG), a long‐established treatment, remains unclear. This study aimed to compare the clinical outcomes of FGF‐2 and ABG and to assess the impact of patient background ...
Toshiki Matsumoto +11 more
wiley +1 more source
Specialty-based differences in osteoporosis management in Türkiye: a national cross-sectional survey. [PDF]
Altunışık MY +3 more
europepmc +1 more source
Abstract Background Periodontitis, a chronic inflammatory disease, is linked to systemic conditions such as cardiovascular and kidney disease. Serum α‐Klotho, an anti‐aging protein with anti‐inflammatory properties, has been associated with systemic diseases, but its role in periodontitis is unclear.
Hamoun Sabri +6 more
wiley +1 more source
The mechanism of action and therapeutic potential of macrophages in osteoporosis: from polarization balance to targeted regulation. [PDF]
Liu C +6 more
europepmc +1 more source
Abstract Background Sodium alendronate (ALN) is widely used to treat postmenopausal osteoporosis, but both estrogen deficiency and antiresorptive therapy may impair alveolar bone repair after tooth extraction. A clinically relevant but insufficiently explored scenario involves estrogen‐deficient individuals receiving hormone replacement therapy (HRT ...
Pedro H. C. Isaias +9 more
wiley +1 more source

